Christina A Penfield, Megan C Oakes, Deysi Caballero, Lindsay N Marty, Dana S Berger, Michael P Nageotte, Jennifer A Mcnulty
{"title":"A Randomized Trial of Postpartum Ibuprofen in Severe Hypertensive Disorders of Pregnancy.","authors":"Christina A Penfield, Megan C Oakes, Deysi Caballero, Lindsay N Marty, Dana S Berger, Michael P Nageotte, Jennifer A Mcnulty","doi":"10.1016/j.ajog.2025.02.012","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Ibuprofen has been shown to increased blood pressure in nonpregnant adults with hypertension, but its impact on blood pressure when used for postpartum analgesia in patients with a hypertensive disorder of pregnancy is less clear, particularly for those with severe hypertension.</p><p><strong>Objective: </strong>To evaluate the impact of ibuprofen on postpartum blood pressure outcomes in patients with hypertensive disorders of pregnancy with severe hypertension.</p><p><strong>Study design: </strong>In this randomized, double-blind trial, we randomly assigned patients with hypertensive disorders of pregnancy with severe hypertension to receive a postpartum analgesic regimen with either ibuprofen 600mg or acetaminophen 650mg (control) every 6 hours. The primary outcome was severe hypertension during postpartum hospitalization. Secondary outcomes included other measures of blood pressure control such as antihypertensive medication use and average postpartum mean arterial pressure, and outpatient blood pressure as well as patient satisfaction, pain control, and diuresis. A sample size of 132 was needed to detect a 35% difference in severe postpartum hypertension.</p><p><strong>Results: </strong>We enrolled 140 participants from January 2017 to October 2019. The prevalence of severe hypertension postpartum did not differ between participants receiving ibuprofen (38.6%) versus control (41.4%); the absolute difference was 2.8 percentage points, 95% confidence interval -13.1% to 18.5%, p= 0.73. There was no difference between the ibuprofen and control groups for antihypertensive medication use (35.7% versus 40.0%, p=0.60) or average postpartum mean arterial pressure (95.7+8.2 versus 95.9+9.5, p=0.91, respectively). Measures of outpatient blood pressure, patient satisfaction, diuresis, and pain control were also similar.</p><p><strong>Conclusion: </strong>In patients with hypertensive disorders of pregnancy with severe hypertension, use of ibuprofen postpartum did not increase the prevalence of postpartum severe hypertension. Ibuprofen use did not impact other blood pressure outcomes, pain control, or patient satisfaction. These findings support ibuprofen use during the postpartum period in patients with hypertensive disorders of pregnancy.</p>","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":" ","pages":""},"PeriodicalIF":8.7000,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of obstetrics and gynecology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajog.2025.02.012","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Ibuprofen has been shown to increased blood pressure in nonpregnant adults with hypertension, but its impact on blood pressure when used for postpartum analgesia in patients with a hypertensive disorder of pregnancy is less clear, particularly for those with severe hypertension.
Objective: To evaluate the impact of ibuprofen on postpartum blood pressure outcomes in patients with hypertensive disorders of pregnancy with severe hypertension.
Study design: In this randomized, double-blind trial, we randomly assigned patients with hypertensive disorders of pregnancy with severe hypertension to receive a postpartum analgesic regimen with either ibuprofen 600mg or acetaminophen 650mg (control) every 6 hours. The primary outcome was severe hypertension during postpartum hospitalization. Secondary outcomes included other measures of blood pressure control such as antihypertensive medication use and average postpartum mean arterial pressure, and outpatient blood pressure as well as patient satisfaction, pain control, and diuresis. A sample size of 132 was needed to detect a 35% difference in severe postpartum hypertension.
Results: We enrolled 140 participants from January 2017 to October 2019. The prevalence of severe hypertension postpartum did not differ between participants receiving ibuprofen (38.6%) versus control (41.4%); the absolute difference was 2.8 percentage points, 95% confidence interval -13.1% to 18.5%, p= 0.73. There was no difference between the ibuprofen and control groups for antihypertensive medication use (35.7% versus 40.0%, p=0.60) or average postpartum mean arterial pressure (95.7+8.2 versus 95.9+9.5, p=0.91, respectively). Measures of outpatient blood pressure, patient satisfaction, diuresis, and pain control were also similar.
Conclusion: In patients with hypertensive disorders of pregnancy with severe hypertension, use of ibuprofen postpartum did not increase the prevalence of postpartum severe hypertension. Ibuprofen use did not impact other blood pressure outcomes, pain control, or patient satisfaction. These findings support ibuprofen use during the postpartum period in patients with hypertensive disorders of pregnancy.
期刊介绍:
The American Journal of Obstetrics and Gynecology, known as "The Gray Journal," covers the entire spectrum of Obstetrics and Gynecology. It aims to publish original research (clinical and translational), reviews, opinions, video clips, podcasts, and interviews that contribute to understanding health and disease and have the potential to impact the practice of women's healthcare.
Focus Areas:
Diagnosis, Treatment, Prediction, and Prevention: The journal focuses on research related to the diagnosis, treatment, prediction, and prevention of obstetrical and gynecological disorders.
Biology of Reproduction: AJOG publishes work on the biology of reproduction, including studies on reproductive physiology and mechanisms of obstetrical and gynecological diseases.
Content Types:
Original Research: Clinical and translational research articles.
Reviews: Comprehensive reviews providing insights into various aspects of obstetrics and gynecology.
Opinions: Perspectives and opinions on important topics in the field.
Multimedia Content: Video clips, podcasts, and interviews.
Peer Review Process:
All submissions undergo a rigorous peer review process to ensure quality and relevance to the field of obstetrics and gynecology.